What is Zivo Bioscience?
Zivo Bioscience, Inc. is a U.S.-based research and development firm dedicated to the study, development, and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. The company's innovative product platform offers algae-based solutions for both animal and human applications, aiming to enhance health benefits such as improved immune response, cholesterol balance, and muscle recovery. These sustainable, plant-based products provide a rich source of protein, fiber, and micronutrients, designed for affordability and adaptability. Zivo Bioscience primarily targets clients within the agricultural sector for animal health solutions and the functional food industry for human health applications.
How much funding has Zivo Bioscience raised?
Zivo Bioscience has raised a total of $17.5M across 1 funding round:
Debt
$17.5M
Debt (2016): $17.5M, investors not publicly disclosed
What's next for Zivo Bioscience?
The recent major strategic investment into Zivo Bioscience signals a pivotal moment for the company, likely enabling accelerated scaling of its operations and further research into its unique algal strain-derived compounds. This capital infusion is expected to fuel expansion into new markets and enhance its product development pipeline, solidifying its position in the animal and human health sectors. The company's focus on sustainable, plant-based nutrition aligns with growing market demand, positioning Zivo Bioscience for significant future growth and innovation in the functional food and animal feed industries.
See full Zivo Bioscience company page
